Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Friday, July 26, 2024.
Arbutus Biopharma Corporation (NASDAQ:ABUS)
Strong Uptrend (+100) - ABUS is in a strong uptrend that is likely to continue. With short-term, intermediate, and long-term bullish momentum, ABUS continues to climb. Traders should protect gains and look for a change in score to suggest a slow down in momentum.
Is it time to buy, sell, or avoid ABUS?
MarketClub looks at technical strength and momentum to determine if the timing is right for ABUS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for ABUS
The long-term trend has been UP since Dec 14th, 2023 at 2.210
The intermediate-term trend has been UP since Jul 8th, 2024 at 3.220
The short-term trend has been UP since Jul 23rd, 2024 at 3.845
Smart Scan Analysis for ABUS
Based on our trend formula, ABUS is rated as a +100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 3.980 | 3.980 | 3.860 | 3.895 | -0.025 |
| Prev. Close | Volume | Bid | Ask | Time |
| 3.920 | 608901 | 2024-07-26 15:59:47 |
| Year High | 12.6 | Year High Date | 2018-08-02 |
| Year Low | 4.01 | Year Low Date | 2018-10-15 |
| 52wk High | 3.98 | 52wk High Date | 2024-07-25 |
| 52wk Low | 1.69 | 52wk Low Date | 2023-10-24 |
| Average Volume | 1,096,839 | Shares Outstanding | 188,717 |
| Market Cap | 103M | Assets | 150,290,000M |
| Liabilities | 35,653,000M | P/E Ratio | -3.08220000 |
| Volatility | 102.46 |